S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Cotinga Pharmaceuticals Inc. (COT.V) Stock Forecast, Price & News

-0.03 (-41.67%)
(As of 10/14/2020)
Today's Range
50-Day Range
52-Week Range
1,000 shs
Average Volume
20,281 shs
Market Capitalization
C$769.51 thousand
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive COT News and Ratings via Email

Sign-up to receive the latest news and ratings for Cotinga Pharmaceuticals Inc. (COT.V) and its competitors with MarketBeat's FREE daily newsletter.

About Cotinga Pharmaceuticals Inc. (COT.V)

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.


IIROC Trading Halt - COT
October 17, 2020 |  markets.businessinsider.com
Cotinga Pharmaceuticals Inc. (COT.V)
March 29, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Year Founded

Sales & Book Value

Annual Sales
Cash Flow
C$0.00 per share
Book Value
C($0.18) per share


Pretax Margin




Free Float
Market Cap
C$769.51 thousand


Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) Frequently Asked Questions

How has Cotinga Pharmaceuticals Inc. (COT.V)'s stock been impacted by Coronavirus (COVID-19)?

Cotinga Pharmaceuticals Inc. (COT.V)'s stock was trading at C$0.03 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, COT shares have increased by 16.7% and is now trading at C$0.04.
View which stocks have been most impacted by COVID-19

Is Cotinga Pharmaceuticals Inc. (COT.V) a good dividend stock?

Cotinga Pharmaceuticals Inc. (COT.V) pays an annual dividend of C$0.24 per share and currently has a dividend yield of 0.00%.

Who are Cotinga Pharmaceuticals Inc. (COT.V)'s key executives?

Cotinga Pharmaceuticals Inc. (COT.V)'s management team includes the following people:
  • Ms. Alison D. Silva, CEO, Pres & Director
  • Dr. Richard T. Ho, Chief Scientific Officer (Age 58, Pay $323.16k)
  • Mr. Victor Hugo C.M.A., C.P.A., Chief Financial Officer (Age 51)
  • Mr. Paul Papi, VP of Investor Relations

What other stocks do shareholders of Cotinga Pharmaceuticals Inc. (COT.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cotinga Pharmaceuticals Inc. (COT.V) investors own include (PRMW), Cascades (CAS), Aurora Cannabis (ACB), Advantage Lithium Corp. (AAL.V) (AAL), InPlay Oil (IPO), Harvest One Cannabis (HVT), Exchange Income (EIF), Datametrex AI (DM), Canadian National Railway (CNI) and Alimentation Couche-Tard (ATD.B).

What is Cotinga Pharmaceuticals Inc. (COT.V)'s stock symbol?

Cotinga Pharmaceuticals Inc. (COT.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "COT."

How do I buy shares of Cotinga Pharmaceuticals Inc. (COT.V)?

Shares of COT and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Cotinga Pharmaceuticals Inc. (COT.V)'s stock price today?

One share of COT stock can currently be purchased for approximately C$0.04.

How much money does Cotinga Pharmaceuticals Inc. (COT.V) make?

Cotinga Pharmaceuticals Inc. (COT.V) has a market capitalization of C$769.51 thousand.

What is Cotinga Pharmaceuticals Inc. (COT.V)'s official website?

The official website for Cotinga Pharmaceuticals Inc. (COT.V) is cotingapharma.com.

Where are Cotinga Pharmaceuticals Inc. (COT.V)'s headquarters?

Cotinga Pharmaceuticals Inc. (COT.V) is headquartered at 100 Collip Cir Suite 230B, LONDON, ON N6G 4X8, Canada.

How can I contact Cotinga Pharmaceuticals Inc. (COT.V)?

Cotinga Pharmaceuticals Inc. (COT.V)'s mailing address is 100 Collip Cir Suite 230B, LONDON, ON N6G 4X8, Canada. The company can be reached via phone at +1-519-8585157.

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.